Ion Exchange FY26 net profit falls 31% to ₹1,432 crore
Ion Exchange (India) Limited reported a 31% decline in FY26 consolidated net profit to ₹1,432 crore, impacted by exceptional costs from new Labour Codes, while revenue from operations grew. The board recommended a dividend of ₹1.25 per share. For Q4FY26, consolidated net profit was ₹243 crore, with the Engineering segment facing disruptions from the West Asia crisis and the Chemicals segment seeing margin pressure from input costs. The company announced strategic collaborations, including a technology transfer with MANN+HUMMEL for membrane technologies, and secured key certifications for its Roha facility.

*this image is generated using AI for illustrative purposes only.
Ion Exchange (India) Limited reported a 31% decline in consolidated net profit to ₹1,432 crore for FY26, down from ₹2,083 crore in the previous year, impacted by exceptional costs related to new Labour Codes. The board, which met on May 26, 2026, approved the audited financial results and recommended a dividend of ₹1.25 per equity share, subject to shareholder approval. The record date for the dividend has been fixed as August 31, 2026. The company submitted its earnings presentation for Q4FY26 and FY26 to the exchanges on May 29, 2026.
Annual Financial Performance
For the full year, standalone revenue from operations grew to ₹267,891 lakh from ₹254,006 lakh, while total standalone income reached ₹277,386 lakh. On a consolidated basis, the company reported a net profit of ₹14,321 lakh for FY26, with total income of ₹300,141 lakh. The statutory auditors issued an unmodified opinion on both the standalone and consolidated financial results. The meeting also addressed the impact of the new Labour Codes, which resulted in an exceptional item of ₹1,454 lakh in standalone results and ₹1,689 lakh in consolidated results due to increased gratuity and leave liabilities.
| Metric | Standalone FY26 (₹ in Lacs) | Standalone FY25 (₹ in Lacs) | Consolidated FY26 (₹ in Lacs) | Consolidated FY25 (₹ in Lacs) |
|---|---|---|---|---|
| Revenue from Operations | 267,891 | 254,006 | 291,484 | 273,711 |
| Total Income | 277,386 | 259,121 | 300,141 | 278,572 |
| Net Profit | 13,838 | 21,448 | 14,321 | 20,825 |
| Basic EPS (₹) | 11.26 | 17.45 | 12.03 | 17.53 |
Segment Performance
The Engineering segment led revenue generation, contributing ₹167,155 lakh in standalone revenue for the year, followed by the Chemicals segment at ₹71,800 lakh. The Consumer Products segment recorded revenue of ₹37,942 lakh. Consolidated revenue for the Engineering segment was ₹175,776 lakh, while the Chemicals segment reported ₹86,772 lakh. The board also approved the appointment of M/s. R. Nanabhoy & Co. as Cost Auditors for the financial year 2026-27.
Q4 Performance
For the quarter ended March 31, 2026, the company reported a consolidated net profit of ₹243 crore on operating income of ₹8,633 crore. On a standalone basis, net profit for Q4FY26 was ₹196 crore on operating income of ₹8,139 crore. The order book stood at ₹26,433 crore as of March 31, 2026, with a bid pipeline of ₹95,090 crore.
Strategic Updates
Management highlighted that the Engineering segment's quarterly revenue was ₹5,539 million, flat year-on-year, with an EBIT of ₹215 million. Planned dispatches to GCC geographies were impacted by disruptions from the West Asia crisis, though customer clearances were received post-quarter. The company successfully commissioned the raw water treatment plant for the IOCL Panipat Refinery project. It also entered into a technology transfer collaboration with MANN+HUMMEL for ultra-filtration membranes and membrane bioreactor technology to strengthen its portfolio.
The Chemicals segment reported quarterly revenue of ₹2,297 million, up 3% year-on-year, with an EBIT of ₹334 million. Profitability was affected by input cost increases and the Roha facility costs, though pricing actions have been initiated. The Roha facility received certification from the Water Quality Association, expected to enhance international market access. The Consumer Products division recorded revenue of ₹1,047 million, a 34% year-on-year increase, with a loss of ₹46 crore compared to ₹52 crore in the previous year.
Historical Stock Returns for Ion Exchange
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.50% | -4.35% | -19.30% | -4.88% | -38.88% | +80.97% |
How will the implementation of the new Labour Codes impact the company's cost structure and operating margins going forward?
What is the expected timeline for realizing revenue from the technology transfer collaboration with MANN+HUMMEL?
How will the company mitigate input cost inflation in the Chemicals segment following the initiated pricing actions?


































